U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944509) titled 'RADIQAL Study (Radiation Dose and Image Quality Trial)' on April 07.
Brief Summary: The Azurion R4.0 is developed by Philips Medical Systems Nederland B.V., a Philips Healthcare company. The Azurion is an interventional X-ray system which is used for live X-ray imaging during invasive cardiac procedures. The proposed Azurion R4.0 includes new x-ray image postprocessing (Xres5) compared to its predecessor, which was equipped with ClarityIQ image post-processing (Xres4).
Azurion R4.0 is a cleared device for EU-MDR and FDA regulated countries.
This is a prospective, randomized, unblinded, comparative, international, multi-center cli...